Effects of single and repeated phencyclidine administration on the expression of metabotropic glutamate receptor subtype mRNAs in rat brain

Shuzo Abe, Toshihito Suzuki, Takehiko Ito, Mika Yamaguchi, Atsuomi Baba, Takafumi Hori, Hirofumi Kurita, Hiroyasu Shiraishi, Nobuo Okado

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Recent animal studies regarding phencyclidine (PCP), which induces psychotic symptoms in humans, have suggested that group II metabotropic glutamate receptors (mGluRs) represent a novel target for the treatment of PCP psychosis. In the present study, we used in situ hybridization to investigate the gene expressions of the mGluR 1-5 subtypes following single and repeated administration of PCP in rats. A single administration of PCP (7.5mg/kg, i.p.,) resulted in a significant decrease in the mGluR5 mRNA expression of group I mGluR in the subcortical regions (thalamus (-15%), central gray (-23%), inferior colliculus (-23%), and nucleus accumbens (-10%)) and hippocampal formation (CA1 (-14%), CA2 (-15%), CA3 (-18%), and dentate gyrus (-18%)). After repeated PCP administration for 14 days, the mGluR2 mRNA expression of group II mGluR in the anterior cingulate cortex (-23%) and the mGluR4 mRNA expression of group III mGluR in the cortical regions (parietal (-11%), temporal (-13%) and entorhinal cortices (-18%)), the caudate putamen (-12%), thalamus (-17%), and subiculum (-25%) were significantly decreased. These results indicate that PCP affects not only group II mGluR but also group I and III of mGluR, and it is of particular interest that mGluR2 subtype is involved in a development of behavioral abnormality following repeated PCP administration. Single and repeated administrations of PCP independently regulate the expression of mGluR subtypes of mRNA in the brain.

Original languageEnglish
Pages (from-to)173-184
Number of pages12
JournalNeuropsychopharmacology
Volume25
Issue number2
DOIs
Publication statusPublished - 2001

Fingerprint

Phencyclidine
Metabotropic Glutamate Receptors
Messenger RNA
Brain
Thalamus
Hippocampus
Inferior Colliculi
Entorhinal Cortex
Parietal Lobe
Putamen
Gyrus Cinguli
Dentate Gyrus
Nucleus Accumbens
Temporal Lobe
Psychotic Disorders
In Situ Hybridization
Gene Expression
metabotropic glutamate receptor 2

Keywords

  • Glutamate
  • In situ hybridization
  • Metabotropic glutamate receptor
  • NMDA antagonist
  • Phencyclidine
  • Schizophrenia

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of single and repeated phencyclidine administration on the expression of metabotropic glutamate receptor subtype mRNAs in rat brain. / Abe, Shuzo; Suzuki, Toshihito; Ito, Takehiko; Yamaguchi, Mika; Baba, Atsuomi; Hori, Takafumi; Kurita, Hirofumi; Shiraishi, Hiroyasu; Okado, Nobuo.

In: Neuropsychopharmacology, Vol. 25, No. 2, 2001, p. 173-184.

Research output: Contribution to journalArticle

Abe, Shuzo ; Suzuki, Toshihito ; Ito, Takehiko ; Yamaguchi, Mika ; Baba, Atsuomi ; Hori, Takafumi ; Kurita, Hirofumi ; Shiraishi, Hiroyasu ; Okado, Nobuo. / Effects of single and repeated phencyclidine administration on the expression of metabotropic glutamate receptor subtype mRNAs in rat brain. In: Neuropsychopharmacology. 2001 ; Vol. 25, No. 2. pp. 173-184.
@article{739ec9f0509e4d6b9b21bd993533d37f,
title = "Effects of single and repeated phencyclidine administration on the expression of metabotropic glutamate receptor subtype mRNAs in rat brain",
abstract = "Recent animal studies regarding phencyclidine (PCP), which induces psychotic symptoms in humans, have suggested that group II metabotropic glutamate receptors (mGluRs) represent a novel target for the treatment of PCP psychosis. In the present study, we used in situ hybridization to investigate the gene expressions of the mGluR 1-5 subtypes following single and repeated administration of PCP in rats. A single administration of PCP (7.5mg/kg, i.p.,) resulted in a significant decrease in the mGluR5 mRNA expression of group I mGluR in the subcortical regions (thalamus (-15{\%}), central gray (-23{\%}), inferior colliculus (-23{\%}), and nucleus accumbens (-10{\%})) and hippocampal formation (CA1 (-14{\%}), CA2 (-15{\%}), CA3 (-18{\%}), and dentate gyrus (-18{\%})). After repeated PCP administration for 14 days, the mGluR2 mRNA expression of group II mGluR in the anterior cingulate cortex (-23{\%}) and the mGluR4 mRNA expression of group III mGluR in the cortical regions (parietal (-11{\%}), temporal (-13{\%}) and entorhinal cortices (-18{\%})), the caudate putamen (-12{\%}), thalamus (-17{\%}), and subiculum (-25{\%}) were significantly decreased. These results indicate that PCP affects not only group II mGluR but also group I and III of mGluR, and it is of particular interest that mGluR2 subtype is involved in a development of behavioral abnormality following repeated PCP administration. Single and repeated administrations of PCP independently regulate the expression of mGluR subtypes of mRNA in the brain.",
keywords = "Glutamate, In situ hybridization, Metabotropic glutamate receptor, NMDA antagonist, Phencyclidine, Schizophrenia",
author = "Shuzo Abe and Toshihito Suzuki and Takehiko Ito and Mika Yamaguchi and Atsuomi Baba and Takafumi Hori and Hirofumi Kurita and Hiroyasu Shiraishi and Nobuo Okado",
year = "2001",
doi = "10.1016/S0893-133X(00)00250-5",
language = "English",
volume = "25",
pages = "173--184",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Effects of single and repeated phencyclidine administration on the expression of metabotropic glutamate receptor subtype mRNAs in rat brain

AU - Abe, Shuzo

AU - Suzuki, Toshihito

AU - Ito, Takehiko

AU - Yamaguchi, Mika

AU - Baba, Atsuomi

AU - Hori, Takafumi

AU - Kurita, Hirofumi

AU - Shiraishi, Hiroyasu

AU - Okado, Nobuo

PY - 2001

Y1 - 2001

N2 - Recent animal studies regarding phencyclidine (PCP), which induces psychotic symptoms in humans, have suggested that group II metabotropic glutamate receptors (mGluRs) represent a novel target for the treatment of PCP psychosis. In the present study, we used in situ hybridization to investigate the gene expressions of the mGluR 1-5 subtypes following single and repeated administration of PCP in rats. A single administration of PCP (7.5mg/kg, i.p.,) resulted in a significant decrease in the mGluR5 mRNA expression of group I mGluR in the subcortical regions (thalamus (-15%), central gray (-23%), inferior colliculus (-23%), and nucleus accumbens (-10%)) and hippocampal formation (CA1 (-14%), CA2 (-15%), CA3 (-18%), and dentate gyrus (-18%)). After repeated PCP administration for 14 days, the mGluR2 mRNA expression of group II mGluR in the anterior cingulate cortex (-23%) and the mGluR4 mRNA expression of group III mGluR in the cortical regions (parietal (-11%), temporal (-13%) and entorhinal cortices (-18%)), the caudate putamen (-12%), thalamus (-17%), and subiculum (-25%) were significantly decreased. These results indicate that PCP affects not only group II mGluR but also group I and III of mGluR, and it is of particular interest that mGluR2 subtype is involved in a development of behavioral abnormality following repeated PCP administration. Single and repeated administrations of PCP independently regulate the expression of mGluR subtypes of mRNA in the brain.

AB - Recent animal studies regarding phencyclidine (PCP), which induces psychotic symptoms in humans, have suggested that group II metabotropic glutamate receptors (mGluRs) represent a novel target for the treatment of PCP psychosis. In the present study, we used in situ hybridization to investigate the gene expressions of the mGluR 1-5 subtypes following single and repeated administration of PCP in rats. A single administration of PCP (7.5mg/kg, i.p.,) resulted in a significant decrease in the mGluR5 mRNA expression of group I mGluR in the subcortical regions (thalamus (-15%), central gray (-23%), inferior colliculus (-23%), and nucleus accumbens (-10%)) and hippocampal formation (CA1 (-14%), CA2 (-15%), CA3 (-18%), and dentate gyrus (-18%)). After repeated PCP administration for 14 days, the mGluR2 mRNA expression of group II mGluR in the anterior cingulate cortex (-23%) and the mGluR4 mRNA expression of group III mGluR in the cortical regions (parietal (-11%), temporal (-13%) and entorhinal cortices (-18%)), the caudate putamen (-12%), thalamus (-17%), and subiculum (-25%) were significantly decreased. These results indicate that PCP affects not only group II mGluR but also group I and III of mGluR, and it is of particular interest that mGluR2 subtype is involved in a development of behavioral abnormality following repeated PCP administration. Single and repeated administrations of PCP independently regulate the expression of mGluR subtypes of mRNA in the brain.

KW - Glutamate

KW - In situ hybridization

KW - Metabotropic glutamate receptor

KW - NMDA antagonist

KW - Phencyclidine

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=0034979643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034979643&partnerID=8YFLogxK

U2 - 10.1016/S0893-133X(00)00250-5

DO - 10.1016/S0893-133X(00)00250-5

M3 - Article

C2 - 11425501

AN - SCOPUS:0034979643

VL - 25

SP - 173

EP - 184

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 2

ER -